Agree. Seems autophagy works in a limited fashion for neurodegenerative disease when unable to make it directly to the brain.
We know that MPL and its metabolite build up nicely in the body AND cross the BBB...im guessing this means autophagy can really do its work and possibly why our results may be vastly superior.
There is just too much setting up for rapid future growth being completed by thr company for this to be a poor outcome. They know this is a winner but just cant say....yet.
IMO
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-167
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $99.76M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $73.08K | 359.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 201331 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 78962 | 1 |
View Market Depth
| Last trade - 14.10pm 10/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |